Literature DB >> 32216920

High-Density Lipoproteins Are the Main Carriers of PCSK9 in the Circulation.

Sean A Burnap, Abhishek Joshi, Sotirios Tsimikas, Carlos Fernández-Hernando, Stefan Kiechl, Sarah E Berry, Wendy Hall, Bodo Levkau, Manuel Mayr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32216920     DOI： 10.1016/j.jacc.2020.01.033

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

Review 1.  Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders.

Authors:  Emma M O'Connell; Falk W Lohoff
Journal:  Front Neurosci       Date:  2020-06-12       Impact factor: 4.677

2.  PCSK9 Activity Is Potentiated Through HDL Binding.

Authors:  Sean A Burnap; Katherine Sattler; Raimund Pechlaner; Elisa Duregotti; Ruifang Lu; Konstantinos Theofilatos; Kaloyan Takov; Gerd Heusch; Sotirios Tsimikas; Carlos Fernández-Hernando; Sarah E Berry; Wendy L Hall; Marlene Notdurfter; Gregorio Rungger; Bernhard Paulweber; Johann Willeit; Stefan Kiechl; Bodo Levkau; Manuel Mayr
Journal:  Circ Res       Date:  2021-10-04       Impact factor: 17.367

3.  Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis-The IMPROVE Study.

Authors:  Daniela Coggi; Beatrice Frigerio; Alice Bonomi; Massimiliano Ruscica; Nicola Ferri; Daniela Sansaro; Alessio Ravani; Palma Ferrante; Manuela Damigella; Fabrizio Veglia; Nicolò Capra; Maria Giovanna Lupo; Chiara Macchi; Kai Savonen; Angela Silveira; Sudhir Kurl; Philippe Giral; Matteo Pirro; Rona Juliette Strawbridge; Bruna Gigante; Andries Jan Smit; Elena Tremoli; Mauro Amato; Damiano Baldassarre
Journal:  Biomedicines       Date:  2021-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.